Orphan designation: 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide monohydrate, Treatment of myelofibrosis, 28/02/2020, Positive

Orphan designation: 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide monohydrate, Treatment of myelofibrosis, 28/02/2020, Positive

SEMrush
Orphan designation: 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide monohydrate, Treatment of myelofibrosis, 28/02/2020, Positive
[automaticbacklinks]